U.S. Newborns Suffer Bleeding as Vitamin K Shot Refusal Rises to 5.2%
Updated
Updated · The New York Times · Jul 8
U.S. Newborns Suffer Bleeding as Vitamin K Shot Refusal Rises to 5.2%
3 articles · Updated · The New York Times · Jul 8
Summary
5.2% of U.S. babies went without the routine vitamin K shot in 2024, up from 2.9% in 2017, leaving tens of thousands more newborns vulnerable to dangerous bleeding.
Doctors say those refusals are translating into more severe cases because vitamin K helps newborn blood clot; without it, babies can suffer spontaneous internal hemorrhages.
One Florida infant whose parents had declined the shot arrived with blood oozing from the umbilical stump and was found to be hemorrhaging internally, requiring IV fluids, emergency vitamin K and a plasma transfusion.
More than 15 doctors told The New York Times they have seen refusals rise further over the past two years, turning what once shocked clinicians into a more regular occurrence.
What convinces parents to refuse a routine shot, making babies 81 times more likely to suffer from life-threatening bleeding?
As a fatal newborn bleeding disorder rises, why isn't the U.S. tracking parental refusals of its simple, one-time cure?
Escalating Vitamin K Shot Refusals Among U.S. Newborns: Data Trends, Health Consequences, and Policy Gaps
Overview
Refusal rates for the routine vitamin K shot in newborns are rising across the United States, putting infants at risk for life-threatening conditions like Vitamin K Deficiency Bleeding, which can cause brain damage or death. This trend is fueled by misinformation, lack of clear information, and parental concerns about injections. The medical community is responding with standardized communication, early education, and targeted outreach, but challenges remain due to fragmented information and growing distrust. Without national tracking, it is difficult to identify high-risk regions or fully understand the impact, highlighting the urgent need for better data and public health strategies.